These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 26111917

  • 1. Risk stratification in acute pulmonary embolism with heart-type fatty acid-binding protein: A meta-analysis.
    Bajaj A, Rathor P, Sehgal V, Shetty A, Kabak B, Hosur S.
    J Crit Care; 2015 Oct; 30(5):1151.e1-7. PubMed ID: 26111917
    [Abstract] [Full Text] [Related]

  • 2. Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolism.
    Langer M, Forkmann M, Richter U, Tausche AK, Sveric K, Christoph M, Ibrahim K, Günther M, Kolschmann S, Boscheri A, Barthel P, Strasser RH, Wunderlich C.
    J Crit Care; 2016 Oct; 35():174-9. PubMed ID: 27481755
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The predictive value of heart-type fatty acid-binding protein is independent from symptom duration in normotensive patients with pulmonary embolism.
    Lankeit M, Dellas C, Benz V, Hasenfuß G, Konstantinides S.
    Thromb Res; 2013 Nov; 132(5):543-7. PubMed ID: 24094603
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of plasma heart-type fatty acid-binding protein in patients with acute pulmonary embolism: a meta-analysis.
    Ruan LB, He L, Zhao S, Zhu P, Li WY.
    Chest; 2014 Dec; 146(6):1462-1467. PubMed ID: 24992229
    [Abstract] [Full Text] [Related]

  • 6. Association of pulmonary artery obstruction index with elevated heart-type fatty acid binding protein and short-term mortality in patients with pulmonary embolism at intermediate risk.
    Gul EE, Can I, Guler I, Yesildag A, Abdulhalikov T, Kayrak M, Ozdemir K, Gok H.
    Diagn Interv Radiol; 2012 Dec; 18(6):531-6. PubMed ID: 22991097
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic Value of Biomarkers in Acute Non-massive Pulmonary Embolism: A Systematic Review and Meta-analysis.
    Bajaj A, Rathor P, Sehgal V, Kabak B, Shetty A, Al Masalmeh O, Hosur S.
    Lung; 2015 Oct; 193(5):639-51. PubMed ID: 26134045
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism.
    Puls M, Dellas C, Lankeit M, Olschewski M, Binder L, Geibel A, Reiner C, Schäfer K, Hasenfuss G, Konstantinides S.
    Eur Heart J; 2007 Jan; 28(2):224-9. PubMed ID: 17127709
    [Abstract] [Full Text] [Related]

  • 12. Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk.
    Boscheri A, Wunderlich C, Langer M, Schoen S, Wiedemann B, Stolte D, Elmer G, Barthel P, Strasser RH.
    Am Heart J; 2010 Aug; 160(2):294-300. PubMed ID: 20691835
    [Abstract] [Full Text] [Related]

  • 13. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism.
    Dellas C, Tschepe M, Seeber V, Zwiener I, Kuhnert K, Schäfer K, Hasenfuß G, Konstantinides S, Lankeit M.
    Thromb Haemost; 2014 May 05; 111(5):996-1003. PubMed ID: 24477222
    [Abstract] [Full Text] [Related]

  • 14. Heart-type Fatty Acid Binding Protein in the Assessment of Acute Pulmonary Embolism.
    Qian HY, Huang J, Yang YJ, Yang YM, Li ZZ, Zhang JM.
    Am J Med Sci; 2016 Dec 05; 352(6):557-562. PubMed ID: 27916210
    [Abstract] [Full Text] [Related]

  • 15. Thrombolysis in patients with pulmonary embolism and elevated heart-type fatty acid-binding protein levels.
    Gul EE, Can I, Kayrak M, Abdulhalikov T, Erdogan HI, Altunbas G, Ozdemir K, Gok H.
    J Thromb Thrombolysis; 2014 May 05; 37(4):483-9. PubMed ID: 24264959
    [Abstract] [Full Text] [Related]

  • 16. A simple score for rapid risk assessment of non-high-risk pulmonary embolism.
    Lankeit M, Friesen D, Schäfer K, Hasenfuß G, Konstantinides S, Dellas C.
    Clin Res Cardiol; 2013 Jan 05; 102(1):73-80. PubMed ID: 23011575
    [Abstract] [Full Text] [Related]

  • 17. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism.
    Kaczyñska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P.
    Clin Chim Acta; 2006 Sep 05; 371(1-2):117-23. PubMed ID: 16698008
    [Abstract] [Full Text] [Related]

  • 18. Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
    Bank IE, Dekker MS, Hoes AW, Zuithoff NP, Verheggen PW, de Vrey EA, Wildbergh TX, Timmers L, de Kleijn DP, Glatz JF, Mosterd A.
    Eur Heart J Acute Cardiovasc Care; 2016 Aug 05; 5(4):364-74. PubMed ID: 25906779
    [Abstract] [Full Text] [Related]

  • 19. Prognostic Value of Right Ventricular Dysfunction Markers for Serious Adverse Events in Acute Normotensive Pulmonary Embolism.
    Weekes AJ, Johnson AK, Troha D, Thacker G, Chanler-Berat J, Runyon M.
    J Emerg Med; 2017 Feb 05; 52(2):137-150. PubMed ID: 27751702
    [Abstract] [Full Text] [Related]

  • 20. The prognostic and risk-stratified value of heart-type fatty acid-binding protein in septic patients in the emergency department.
    Chen YX, Li CS.
    J Crit Care; 2014 Aug 05; 29(4):512-6. PubMed ID: 24768564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.